blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4198034

EP4198034 - BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  19.05.2023
Database last updated on 14.06.2024
FormerThe international publication has been made
Status updated on  21.02.2022
Most recent event   Tooltip15.12.2023Supplementary search reportpublished on 17.01.2024  [2024/03]
15.12.2023Change - classificationpublished on 17.01.2024  [2024/03]
15.12.2023Change - classificationpublished on 17.01.2024  [2024/03]
Applicant(s)For all designated states
Tuojie Biotech (Shanghai) Co., Ltd.
Room 103, No. 14 Building
No. 3728 Jinke Road
Free Trade Pilot Zone
Pudong New District
Shanghai 201203 / CN
[2023/25]
Inventor(s)01 / LI, Wenming
Shanghai 201203 / CN
02 / LIU, Ning
Shanghai 201203 / CN
03 / LIU, Biao
Shanghai 201203 / CN
04 / LIU, Haomiao
Shanghai 201203 / CN
05 / YU, Jian
Shanghai 201203 / CN
06 / ZOU, Hao
Shanghai 201203 / CN
07 / ZHU, Wei
Shanghai 201203 / CN
08 / LI, Zhengtao
Shanghai 201203 / CN
09 / ZHANG, Zhen
Shanghai 201203 / CN
10 / LI, Yunfei
Shanghai 201203 / CN
 [2023/25]
Representative(s)Dragotti & Associati S.R.L., et al
Via Nino Bixio, 7
20129 Milano / IT
[N/P]
Former [2023/25]Viganò, Elena, et al
Dragotti & Associati S.r.l.
Via Nino Bixio, 7
20129 Milano / IT
Application number, filing date21855617.313.08.2021
[2023/25]
WO2021CN112386
Priority number, dateCN20201081126713.08.2020         Original published format: CN202010811267
CN20211060930501.06.2021         Original published format: CN202110609305
[2023/25]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022033567
Date:17.02.2022
Language:ZH
[2022/07]
Type: A1 Application with search report 
No.:EP4198034
Date:21.06.2023
Language:EN
[2023/25]
Search report(s)International search report - published on:CN17.02.2022
(Supplementary) European search report - dispatched on:EP14.12.2023
ClassificationIPC:C07D413/06, A61K31/5377, A61P13/00, A61P25/04, A61P11/14
[2023/25]
CPC:
C07D413/14 (EP,KR,US); A61K31/5377 (EP,KR); A61K31/538 (KR);
A61K31/5415 (KR); A61P11/14 (EP,KR); A61P13/00 (EP);
A61P13/02 (KR); A61P25/04 (EP,KR); C07D413/06 (EP,KR,US);
C07D417/14 (EP,KR,US); C07D419/14 (US); C07B2200/05 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/25]
TitleGerman:BENZIMIDAZOLDERIVATE, HERSTELLUNGSVERFAHREN DAFÜR UND MEDIZINISCHE VERWENDUNG DAVON[2023/25]
English:BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF[2023/25]
French:DÉRIVÉS DE BENZIMIDAZOLE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION MÉDICALE[2023/25]
Entry into regional phase22.02.2023Translation filed 
22.02.2023National basic fee paid 
22.02.2023Search fee paid 
22.02.2023Designation fee(s) paid 
22.02.2023Examination fee paid 
Examination procedure22.02.2023Amendment by applicant (claims and/or description)
22.02.2023Examination requested  [2023/25]
Fees paidRenewal fee
18.08.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YA]WO2011062550  (ASTRAZENECA AB [SE], et al) [Y] 1,2,5,6,12-15 * Formula (I)-(III) Reason for proviso within the defibnition of R7; pages 2-6; claims 1-19; table 1 * [A] 3,4,7-11;
 [X]CN102741245  (ASTRAZENECA AB);
 [YA]WO2012158117  (ASTRAZENECA AB [SE], et al) [Y] 1,2,5,6,12-15 * Formula (I) Examples Reason for proviso within the defibnition of R7;; tables 1,2 * [A] 3,4,7-11;
 [I]WO2014117274  (NEOMED INST [CA]) [I] 1-15 * Formula (I); Examples Imidazopyridines instead of the present benzimidazole; page 2; table 2 *;
 [I]WO2020135771  (WUHAN LL SCIENCE AND TECH DEVELOPMENT CO LTD [CN], et al)[I] 1-15;
 [E]EP3889154  (WUHAN LL SCIENCE AND TECH DEVELOPMENT CO LTD [CN]) [E] 1-15 * Imidazopyridines instead of the present benzimidazole; pages 242, 246 - page 250; examples 2,101,171 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.